To our knowledge, it is the first to comprehensively assess both the prevalence and serum levels of anti-TPO and anti-TG antibodies in women with and without PCOS, while taking into account important methodological factors such as TSH- and BMI-matching. The gene discussed is TPO; the disease is polycystic ovary syndrome.